This webinar will take a practical look at why manufacturers need to be aware of recent significant reforms in several countries regarding reference pricing, comparative effectiveness research, transparency and mandatory pricing “negotiation” requirements that will significantly alter strategies for a successful market launch and maintenance of pricing throughout a product’s lifecycle.
Panelists
Maarten Meulenbelt EU Transparency Directive
Felix Von Bredow German drug pricing reform
Bill Sarraille US pricing and comparative effectiveness research
Katherine Wang Prospective changes in drug price controls in China
Sidley Austin’s Global Life Sciences Practice presents
WHAT’S NEXT?
A series of presentations on emerging legal issues across the life sciences arena:
-
Global Drug and Biotech Pricing: Risk and Rewards in an Evolving World Market
-
Bridging the Value Gap: Options, Earnouts and other Alternative Structures for Life Science Transactions
-
GMP Enforcement Eye: Current Trends and Emerging Issues
-
A Small World: Evolving Tort Standards and Developments Around the Globe
-
A Changing International Landscape: Patent Procurement and Enforcement
RSVP via email to dcevents@sidley.com.
Sidley Austin LLP is an accredited MCLE provider in IL, NY and CA. Portions of this program will qualify.